OncoMark are awarded €2.7 million by the European Commission to develop a diagnostic assay for breast cancer
OncoMark are pleased to announce they have been awarded €2.7 million by the European Commission, for the commercial development of a new Diagnostic test for breast cancer patients. This award will fund the development and commercialisation of OncoMasTR, a novel prognostic assay for early stage breast cancer that will reduce the number of breast cancer patients receiving unnecessary chemotherapy.
Mr Desmond O'Leary joins OncoMark as Chief Executive
We are pleased to announce the appointment of Mr Desmond O Leary to the position of Chief Executive Officer of OncoMark. Mr O Leary is an experienced executive with over 20 years in the diagnostic industry.
OncoMark wins Medical Laboratory of the Year at 2014 Irish Laboratory Awards
CEO of OncoMark, Dr Máirín Rafferty collects the award for Medical Laboratory of the Year at this year's Irish Laboratory Awards held in Dublin on Wednesday, 3rd December 2014.
Joe Barry, Managing Director of Lennox presents the award.